Stock Scorecard



Stock Summary for Third Harmonic Bio Inc (THRD) - $11.15 as of 4/30/2024 12:44:56 PM EST

Total Score

14 out of 29

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for THRD

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for THRD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for THRD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for THRD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for THRD

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors 3/28/2024 12:30:00 PM
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results 3/26/2024 12:05:00 PM
Are You Looking for a Top Momentum Pick? Why Third Harmonic Bio, Inc. ( THRD ) is a Great Choice 12/29/2023 5:00:00 PM
Third Harmonic Bio Announces Third Quarter 2023 Financial Results 11/9/2023 1:30:00 PM
Third Harmonic Bio Announces Leadership Changes - Third Harmonic Bio ( NASDAQ:THRD ) 10/31/2023 12:30:00 PM
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference 8/31/2023 12:30:00 PM
Third Harmonic Bio Announces Second Quarter 2023 Financial Results 8/10/2023 12:10:00 PM
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335 - Third Harmonic Bio ( NASDAQ:THRD ) 7/25/2023 12:30:00 PM
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335 7/25/2023 12:30:00 PM
Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results 3/29/2023 12:05:00 PM

Financial Details for THRD

Company Overview

Ticker THRD
Company Name Third Harmonic Bio Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/9/2024

Stock Price History

Last Day Price 11.15
Last Day Price Updated 4/30/2024 12:44:56 PM EST
Last Day Volume 65,737
Average Daily Volume 182,702
52-Week High 12.42
52-Week Low 4.31
Last Price to 52 Week Low 158.70%

Valuation Measures

Trailing PE N/A
Industry PE 67.70
Sector PE 53.36
5-Year Average PE -4.91
Free Cash Flow Ratio 1.69
Industry Free Cash Flow Ratio 12.73
Sector Free Cash Flow Ratio 30.86
Current Ratio Most Recent Quarter 50.29
Total Cash Per Share 6.60
Book Value Per Share Most Recent Quarter 6.71
Price to Book Ratio 1.74
Industry Price to Book Ratio 5.66
Sector Price to Book Ratio 22.00
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 5.48
Sector Price to Sales Ratio Twelve Trailing Months 5.14

Share Statistics

Total Shares Outstanding 40,756,800
Market Capitalization 454,438,320
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 12.32%
Reported EPS 12 Trailing Months -0.78
Reported EPS Past Year 0.00
Reported EPS Prior Year -0.98
Net Income Twelve Trailing Months -30,824,000
Net Income Past Year -30,824,000
Net Income Prior Year -35,155,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 413.03%

Balance Sheet

Total Cash Most Recent Quarter 269,070,000
Total Cash Past Year 269,070,000
Total Cash Prior Year 288,877,000
Net Cash Position Most Recent Quarter 269,070,000
Net Cash Position Past Year 269,070,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 269,085,000
Total Stockholder Equity Prior Year 289,068,000
Total Stockholder Equity Most Recent Quarter 269,085,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.34
MACD Signal 0.44
20-Day Bollinger Lower Band 8.45
20-Day Bollinger Middle Band 10.24
20-Day Bollinger Upper Band 12.03
Beta 0.00
RSI 52.26
50-Day SMA 7.82
200-Day SMA 0.00

System

Modified 4/30/2024 12:45:42 PM EST